Primary laryngeal manifestation in precursor T-cell acute lymphoblastic leukemia
- Authors:
- Lin Wang
- Yan Ma
- Bobin Chen
- Feng Tang
- Xiaoping Xu
- Guowei Lin
View Affiliations
Affiliations: Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Department of Pathology, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
- Published online on: December 12, 2014 https://doi.org/10.3892/ol.2014.2800
-
Pages:
691-694
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Primary involvement of the larynx in non‑Hodgkin's lymphoma (NHL) is rare. Early symptoms are non‑specific and thus, it is difficult to diagnose. In the present study, the case of a 52 year‑old male with hoarseness due to diffuse T‑cell lymphoma as the first manifestation of precursor T‑cell acute lymphoblastic leukemia is presented. Subsequent to treatment with three cycles of the etoposide and cytosine arabinoside (EA) and one cycle of the EA+L‑asp chemotherapy regimens, the patient achieved complete remission. A series of consolidation therapy courses were performed subsequently. At present, the patient remains disease‑free, indicating that the treatment was effective. Primary involvement of the larynx in NHL is rare. Symptoms in the early stage are subtle and non‑specific and thus, diagnosis is difficult to establish. This type of tumor requires special diagnostic and therapeutic attention.
View References
1
|
Laurini JA, Perry AM, Boilesen E, et al:
Classification of non-Hodgkin lymphoma in Central and South
America: a review of 1028 cases. Blood. 120:4795–4801. 2012.
View Article : Google Scholar : PubMed/NCBI
|
2
|
King AD, Yuen EH, Lei KI, Ahuja AT and Van
Hasselt A: Non-Hodgkin Lymphoma of the larynx: CT and MR imaging
findings. AJNR Am J Neuroadiol. 25:12–15. 2004.
|
3
|
Lin X, Shi X, Zeng W, Zheng M and Huang L:
Salvage therapy with mitoxantrone, etoposide, bleomycin and
dexamethasone for refractory or relapsed aggressive non-Hodgkin’s
lymphoma patients with a poor performance status or comorbidity.
Oncol Lett. 8:2012–2016. 2014.PubMed/NCBI
|
4
|
Markou K, Goudakos J, Constantinidis J, et
al: Primary laryngeal lymphoma: report of 3 cases and review of the
literature. Head Neck. 32:541–549. 2010.
|
5
|
Vega F, Lin P and Medeiros LJ: Extranodal
lymphomas of the head and neck. Ann Diagn Pathol. 9:340–350. 2005.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kovac L, Bilić M, Bumber B and Topić I:
Primary laryngeal manifestation in precursor T-cell acute
lymphoblastic leukemia. Otolaryngol Head Neck Surg. 139:474–475.
2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Uyttebroeck A, Vanhentenrijk V, Hagemeijer
A, et al: Is there a difference in childhood T-cell acute
lymphoblastic leukaemia and T-cell lymphoblastic lymphoma? Leuk
Lymphoma. 48:1745–1754. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Campo E, Swerdlow SH, Harris NL, Pileri S,
Stein H and Jaffe ES: The 2008 WHO classification of lymphoid
neoplasms and beyond: evolving concepts and practical applications.
Blood. 117:5019–5032. 2011. View Article : Google Scholar : PubMed/NCBI
|